<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0003674'>Oxidative stress</z:mp> and <z:chebi fb="15" ids="39026">LDL</z:chebi> modification (oxLDL) are early pro-atherogenic events </plain></SENT>
<SENT sid="1" pm="."><plain>OxLDL binds beta2GPI producing immunogenic oxLDL/beta2GPI complexes </plain></SENT>
<SENT sid="2" pm="."><plain>Antibodies to these complexes have been associated with <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> in patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) and <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) </plain></SENT>
<SENT sid="3" pm="."><plain>Circulating oxLDL/beta2GPI complexes, IgG and IgM antibodies to these complexes were measured by ELISA in 30 SLE patients asymptomatic for <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> (mean age 31 years) and 27 age/sex matched healthy controls </plain></SENT>
<SENT sid="4" pm="."><plain>Carotid intima-media thickness (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>) was measured by ultrasound in <z:hpo ids='HP_0000001'>all</z:hpo> patients and controls </plain></SENT>
<SENT sid="5" pm="."><plain>Forty-seven percent of SLE presented plaques (median <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> of 0.65 +/- 0.12 mm) while only 7% of the controls had plaques (median <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> of 0.50 +/- 0.04 mm, P &lt; 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>Median optical density (OD450nm) for oxLDL/beta2GPI complexes in SLE was 0.244 +/- 0.07, higher than controls (0.174 +/- 0.09, P &lt; 0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>Median OD for IgG anti-oxLDL/beta2GPI antibodies was also higher in SLE (0.297 +/- 0.26) compared to controls (0.194 +/- 0.07, P &lt; 0.001) while the median OD for IgM antibodies in SLE (0.444 +/- 0.46) was not different than controls (0.326 +/- 0.22, P = 0.267) </plain></SENT>
<SENT sid="8" pm="."><plain>There was no correlation between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> and oxLDL/beta2GPI complexes, IgG or IgM antibodies, possibly reflecting the complex interrelationship between these serologic elements and tissue factors in the arterial wall </plain></SENT>
<SENT sid="9" pm="."><plain>These results support the hypothesis that oxLDL/beta2GPI complexes and IgG (not IgM) anti-oxLDL/beta2GPI antibodies contribute to the development of autoimmune-mediated <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
</text></document>